Monday, April 25, 2016

Advisers to F.D.A. Vote Against Duchenne Muscular Dystrophy Drug


By ANDREW POLLACK from NYT Business Day http://www.nytimes.com/2016/04/26/business/muscular-dystrophy-drug-fda-sarepta-eteplirsen.html?partner=IFTTT
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)